Clinical thinking of treatment with bronchodilator

Ming LU,Ying-yun CAI

DOI: https://doi.org/10.3760/cma.j.issn.1673-436X.2006.01.024

2006-01-01

Abstract:喘息是最常见的症状之一,影响人们的学习、生活、工作和睡眠,甚至危及生命.如何合理使用平喘药物是临床医学的重要课题.正确的临床思维是首先和必要的.平喘药物治疗的临床思维包括思维基础和思维要点两部分.

What problem does this paper attempt to address?

Clinical Thinking on Diagnosis and Treatment of Pediatric Respiratory Infections

Chen Zhimin

DOI: https://doi.org/10. 3760/cma. j. issn. 2095-428x. 2019. 04. 002

2019-01-01

Abstract:Respiratory infections have heterogeneous causes and variable manifestations. How to make an indi-vidual and correct judge for each pediatric respiratory infection and make the patients receive an individualized and ra-tional therapy,according to the principles and methods of clinical thinking,is a great challenge for every pediatrician, each day. Based on a briefly introduction of features of clinical thinking,this article focus on key principles in the diag-nosis and treatment of pediatric respiratory infections.
The clinical thinking about treatment of obstructive sleep apnea hyponea syndrome

Xiao-yan JIN,Ying-yun CAI

DOI: https://doi.org/10.3760/cma.j.issn.1673-436X.2006.06.025

2006-01-01

Abstract:阻塞性睡眠呼吸暂停低通气综合征(OSAHS)是一种常见的临床病症,除了睡眠打鼾、憋气,白天嗜睡等诸多症状外,还可引起一系列靶器官受损.OSAHS的治疗涉及多个学科,需要综合性治疗,正确的临床思维是必不可少的。
Continuing Medical Education Clinical thinking of treatment of pneumothorax

Jian-rong CHEN,Ying-yun CAI,Bao-chun CHEN

DOI: https://doi.org/10.3760/cma.j.issn.1673-436X.2006.10.023

2006-01-01

Abstract:气胸是最常见的肺胸疾病之一,进行正确、及时和有效的治疗十分重要.气胸治疗前需掌握病情、患者的特点以及各种治疗方法的适用证、禁忌证等.在进行气胸治疗时,应考虑其目的、治疗方法的选择、制定具体方案、决定监测项目和预防复发的措施,并分析影响疗效的因素。
Clinical Thinking on Diagnosis and Treatment of Childhood Bronchiolitis

Yin Yong,Chen Jiande

DOI: https://doi.org/10. 3760/cma. j. issn. 2095-428x. 2019. 04. 003

2019-01-01

Abstract:Although children bronchiolitis is often encountered in the clinical practice of pediatricians,the diagnosis and treatment of bronchiolitis in children is quite difficult because of its varied clinical manifestation and non-specific imaging. In this paper,the anatomy,definition,etiological classification,diagnosis,differential diagnosis,and therapeutic principles of bronchiolitis in children will be discussed. Then the diagnosis and therapy of bronchiolitis based on different etiology will be explored.
Clinical thinking of mechanical ventilatim

Jian-rong CHEN,Ying-yun CAI

DOI: https://doi.org/10.3760/cma.j.issn.1673-436X.2006.03.024

2006-01-01

Abstract:机械通气治疗是重症抢救中最常用的治疗方法和手段之一,实施机械通气前需掌握病情和患者的特点以及机械通气的有关知识.实施机械通气时,应考虑机械通气的目的、适应证、禁忌证和可行性,制定具体方案,决定监测项目和指标,判断撤机的可能和决定撤机的方法,并分析影响疗效的因素。
A retrospective study of the treatment of patients hospitalized for asthma exacerbation in China

Bin Xing,Jiangtao Lin,Huaping Tang,Lan Yang,Yadong Yuan,Yuhai Gu,Ping Chen,Xiaoju Liu,Jie Zhang,Huiguo Liu,Changzheng Wang,Wei Zhou,Dejun Sun,Yiqiang Chen,Zhuochang Chen,Mao Huang,Qichang Lin,Chengping Hu,Xiaohong Yang,Jianmin Huo,Xianwei Ye,Xin Zhou,Ping Jiang,Wei Zhang,Yijiang Huang,Luming Dai,Rongyu Liu,Shaoxi Cai,Jianying Xu,Jianying Zhou

DOI: https://doi.org/10.3760/cma.j.issn.0376-2491.2018.08.014

2018-01-01

Abstract:Objective To study the treatment of patients hospitalized for asthma exacerbation in China.Methods This was a retrospective study and involved patients hospitalized for asthma exacerbation in 29 hospitals throughout China during Jan 2013 to Dec 2014.Information of the demographic features,the severity of the exacerbation,the medicine prescribed during the hospitalization and the use of mechanical ventilation were collected and analyzed.Results During the study period,there were 3 240 patients hospitalized for asthma exacerbation,and 1 369(42.3％) of them were males 1 871 (57.7％)were females.Patients of mild,moderate,severe,and life-threatening exacerbation counted for 41.7％,37.8％,19.2％ and 1.0％,respectively of the total patients.Of all the patients,72.6％ used bronchodilators by nebulizer,70.8％ used inhaled corticosteroids by nebulizer,60.5％ used intravenous corticosteroids,17.3％ used oral corticosteroids,and 80.5％ used antibiotics.The percentages of patients using systemic corticosteroids and antibiotics were higher in patients with more severe exacerbation.In patients with mild exacerbation,there were 74.9％ and 52.2％ who used antibiotics and systemic corticosteroids,respectively.A total of 73 patients (2.3％) used mechanical ventilation,and 62 of them used noninvasive ventilation,16 used invasive ventilation,and 5 used both.Conclusions Nebulizer therapy has been accepted as the main administration route of medicine in the treatment of asthma exacerbation.A large amount of patients used antibiotics and systemic corticosteroids during hospitalization,indicating there may be some overuse of these medicines.
The patient who affects an asthma uses bronchus relaxation agent factor and countermeasure

LI Wei,SONG Chen,CAO Jian-fen

DOI: https://doi.org/10.3969/j.issn.1672-9676.2011.01.025

2011-01-01

Abstract:Objective:The preliminary investigation and discussion effect asthma patient uses bronchus relaxation agent factor and answer measure.Methods The questionnaire made by self applying this yard inquires into the influencing factor analysing 134 example asthmas patients using the bronchus relaxation agent. Results:Rightness sucks bronchus relaxation agent person in among 134 regular patients 68 examples, account for 50.7% only.The affect factors of patient aspect such as using bronchus relaxation agent factor to worry about that the medicine side effect,medical science knowledge are deficient mainly including the patient ,curing special field ability difference , low and their deficiency healthy quality educational work lacking confidence,being in financial straits , nursing staff. Conclusions:The patient who affects an asthma uses bronchus relaxation agent factor many, the pertinency adopts necessaries answering measure, to improve it's comply with, boost it's early phase recovering from the illness.
Analysis of the Correct Use of Inhaled Medicines in Patient with Chronic Airway Diseases

ZHANG Zhen-hua,CHEN Bing

DOI: https://doi.org/10.6039/j.issn.1001-0408.2013.42.28

2013-01-01

Abstract:OBJECTIVE:To investigate the rate of correct use of inhaled medicines in the clinic. METHODS:330 patients with chronic airway diseases were selected from the outpatient chronic airway disease of respiratory department in a hospital. They conducted a questionnaire survey to understand the use of inhaled medicines. RESULTS:326 valid questionnaires were collected. The rates of improper use of different devices were 17.9%-36.4%. However,the rate of incorrect use of patients by two different devices simultaneously was 7.4%. There were two reasons:firstly,patients used two devices usually suffered from severe illness; more attention was paid to control their disease,and they had better compliance. Secondly,severe patients may spend more time on communicating with physicians;meanwhile,doctors were willing to provide more guidance to patients. The frequent communications helped to reduce the error-use rate. CONCLUSIONS:There are still many patients who cannot correctly use inhalation devices. This may have a strong influence on drug effects and thus delay the treatment of the diseases. Therefore,clinicians and pharmacists should pay attention to the standard guidance on the correct use of inhaled medicines.
Clinical Differential Diagnosis in Bronchial Asthma Patients with Chest Tightness Suggestive of Coronary Heart Disease by Peak Flow Meter

Yi ZHU-GE,Jian-ying ZHOU

DOI: https://doi.org/10.3969/j.issn.1007-0931.2005.07.004

2005-01-01

Abstract:Objective To explore effective clinical approaches for differential diagnosis in bronchial asthma patients with chest tightness suggestive of coronary heart disease (CHD) and to reduce misdiagnoses in those patients. Methods 26 patients with chest tightness suggestive of CHD were given a standardized physical examination and indicated no wheezing sound in their chests. Forced peak expiratory flow (PEF) was then measured by a peak flow meter. Bronchodilator response was presumed positive if PEF improved rate was above15 percent of predictive value after 200μg salbutamol inhaled for each subject. The following spirometry was performed with a MANENTA 600 for further confirmation in those who previously tested positive by PEF. Results A total of 16 patients who suggested positive by PEF were verified to suffer bronchial asthma, which accounting for 61.54%. Another 10 patients with improved PEF above 6% of predictive value were involved in suspected bronchial asthma. Conclusion It is an effective and noninvasive clinical method of differential diagnosis in bronchial asthma patients with chest tightness suggestive of CHD to employ peak flow meter with PEF test for bronchodilator response.
Clinical thought of signs and symptoms

Xiao-ye HE,Ying-yun CAI

DOI: https://doi.org/10.3760/cma.j.issn.1673-436X.2006.05.022

2006-01-01

Abstract:症状和体征的临床思维是指临床医生以患者主观的不适感受和客观的检查体征为出发点,对临床资料进行综合分析和逻辑推理,随后做出鉴别判断和诊断以及指导和调整治疗的过程.症状和体征的临床思维包括思维基础和思维要点两部分。
Clinical Thinking of Drug Therapy Decisions

叶晓芬,蔡映云,金美玲,吕迁洲

DOI: https://doi.org/10.12014/j.issn.1002-0772.2017.03b.02

2017-01-01

Abstract:In order to form correct drug treatment decision,we should judge comprehensively the diagnosis,illness,patient and pharmacy.Firstly,the perfect diagnosis should include not only all the contents of the diagnosis,but also all the diseases that the patient suffered from.Secondly,full assessment of illness condition should be made,including the risk factors,disease characteristics,disease progression and prognosis.Thirdly,individual assessing patient is also important,including the biological characteristics of the patients,as well as society and cultural background.Fourthly,assessment of treatment protocol should be done,including the overall arrangement of treatments measures,drug therapeutic schedules,implementation and response of the treatment plan.
Clinical thinking of artificial airway

Jian-rong CHEN,Ying-yun CAI,Chuan-hua HE

DOI: https://doi.org/10.3760/cma.j.issn.1673-436X.2006.12.022

2006-01-01

Abstract:建立人工气道是抢救呼吸衰竭最常用治疗方法之一,实施前需掌握正常气道的解剖特点、病情和患者的特点以及人工气道的有关知识.建立人工气道时,应考虑其目的、适应证、禁忌证和可行性,制定具体方案,决定监测项目和指标,并分析影响疗效的因素。
[Attitudes and Actions of Chronic Obstructive Pulmonary Disease Patients on Treatment:A National Multi-Center Investigative Study].

Ya-Hong Chen,Wan-Zhen Yao,Jian Kang,Bai-Qiang Cai,Xin Zhou,Zheng Liu,Ping Chen,De-Jun Sun,Jing-Ping Zheng,Guo-Yang Wang,Yu-Lin Feng,Yong-Jian Xu,Yan Jia,Ming Lu,Chun Chang,Xiao-Hong Wang

DOI: https://doi.org/10.3760/cma.j.issn.1001-0939.2010.10.010

2010-01-01

Abstract:OBJECTIVE:To investigate the attitudes and actions of patients with chronic obstructive pulmonary disease (COPD) on treatment.METHODS:A nation-wide multi-center, questionnaire study was carried out to investigate the patient understanding and experience of COPD treatment between Sep. 2007 and Dec. 2008. The questionnaire included the patients' understanding of goal of COPD treatment, previous treatment, and expectation on drugs. The data were analyzed by descriptive statistical methods.RESULTS:2072 patients with COPD in 11 centers were interviewed in the study. The final effective questionnaires were collected from 1698 cases. 653 patients had known of COPD. The attitudes and actions on treatment were analyzed based on these patients. The patients had different understanding of goals for COPD treatment, including 59.1% (384/650) for relieving symptoms. In recent 3 months, the most commonly used drugs were theophylline (53.7%, 351/653), iprotropium (39.8%, 260/653), tiotropium (27.1%, 177/653). 72.0% (465/646) patients used the drugs according to the prescriptions. There were more than 80% patients who did not understand the side effects of anti-cholinergics, β-adrenergic agonists, inhaled steroids, inhaled steroid/long-acting β-agonist combination therapy, or theophyllines. 37.4% (240/641) patients were afraid of side effects of inhaled steroids. 42.2% (274/650) patients often took antibiotics. There was no oxygen supply at home in 60.1% (391/651) patients. 70.5% (457/648) did not have pulmonary rehabilitation. Requirement of long-term regular treatment was considered in 77.4% (500/646) patients. The most important thing about patients' attitude on ideal drugs for COPD was drug efficacy (79.6%, 481/604). The most ideal drug used in the past was fluticasone/salmeterol or tiotropium (16.9%, 78/461).CONCLUSIONS:Patients had different attitudes and actions on COPD treatment. Patient education should be strengthened to realize treatment goals for COPD.
Assessment of Inhalation Technique in Clinical and Functional Control of Asthma and Chronic Obstructive Pulmonary Disease

Tiago Maricoto,Luís Vaz Rodrigues,Gilberto Teixeira,Carla Valente,Lília Andrade,Alcina Saraiva

DOI: https://doi.org/10.20344/amp.5905

Abstract:Introduction: Chronic obstructive pulmonary disease and asthma affect almost 300 million individuals. Inhaled therapy is often associated with technical errors reducing efficacy and compliance. Objective: To evaluate the inhalation technique and its relation with clinical and functional control in asthma and chronic obstructive pulmonary disease. Material and methods: Analytical cross-sectional study including patients with asthma and chronic obstructive pulmonary disease treated with any type of inhaler device. Demographic data and inquiry about previous teaching of inhalation technique were collected in all participants. Inhalation technique was evaluated in: Step 1 - device activation; Step 2 - previous expiration; Step 3 - inspiration; Step 4 - end inspiratory pause. Clinical control was assessed from the questionnaires Asthma Control Test, Control of Allergic Rhinitis and Asthma Test, modified Medical Research Council and Chronic Obstructive Pulmonary Disease Assessment Test. Spirometric evaluation was performed in all participants. Results: From a total of 62 subjects, 74.19% made at least one error, mainly during step 2 (53.2%). Previous education on inhalation technique was associated with lower number of errors (p = 0.014). There was no association between number of errors and age (p = 0.321), years of diagnosis (p = 0.119) or spirometric evaluation (p > 0.05). In asthma an association was found between number of errors and Asthma Control Test (p = 0.032) and Control of Allergic Rhinitis and Asthma Test (p = 0.008). Discussion and conclusion: Teaching inhalation technique has a positive impact on its future performance. Most patients make mistakes, affecting clinical control in asthma, although in chronic obstructive pulmonary disease no relation was found. This is an ongoing work that aims to reevaluate inhalation technique after patients' education and its further impact.
Treat the lungs, fool the brain and appease the mind: towards holistic care of patients who suffer from chronic respiratory diseases

Thomas Similowski

DOI: https://doi.org/10.1183/13993003.00316-2018

IF: 24.3

2018-02-01

European Respiratory Journal

Abstract:In healthy people, breathing is the most natural thing in the world. No need to think about it. No need to be concerned about it. It is not even the object of conscious perception. But when breathing becomes difficult, when it produces suffering, nothing else mattersa. Life discolours and shrinks around an act of breathing that has become elusive and uncertain, but pervasive. Disability ensues, which adds “a variety of adverse psychosocial, spiritual, or other consequences” to the respiratory-related physical limitations [1]. Respiratory suffering, be it called dyspnoea, breathlessness or by any other name, is therefore a major (and probably often the main) driver of impaired quality of life in patients afflicted with chronic respiratory diseases (and also cardiac diseases, neuromuscular diseases and severe obesity). To put things more bluntly, not being able to breathe freely is probably the worst thing that can happen to a human being. Dyspnoea has long been compared to pain [2] and has a lot of neurophysiological similarities with it [3, 4]. Yet in many ways dyspnoea is probably worse than pain. Indeed, acute dyspnoea goes hand in hand with fear, the fear of dying, which is not systematically the case with pain. And, not being a universal experience like pain, dyspnoea might be less susceptible than pain to induce reactions and empathy from those who witness it. Trained healthcare professionals dealing with respiratory distress on a daily basis fail to correctly evaluate the dyspnoea of their patients [5], and even though recent evidence suggests that vicarious dyspnoea does exist in a manner that resembles vicarious pain [6], the dyspnoea of chronic diseases tends to become invisible to caregivers [7]. This is perhaps because medical responses to dyspnoea are less codified and less efficient than responses to pain, but this phenomenon can only amplify the negative consequences of dyspnoea on the psychology of those experiencing it [7, 8]. Yet, as emphasised by Başoğlu [8] in a recent editorial, failure to enquire about, assess and properly treat breathlessness as outlined in specialist clinical guidelines is a breach of clinicians' ethical and legal duties to patients (see also [9]). On top of this clinical importance, respiratory suffering is the point of convergence and the final pathway of an array of diseases that at times have little in common and of which the specialists can have trouble understanding each other. In other words, dyspnoea is the “unifier” of respiratory medicine with all its diversity. For all these reasons, dyspnoea should be a foremost concern for all healthcare professionals, a primary criterion in clinical research, and the focus of specific multidisciplinary research efforts. Fortunately there are indications that this is becoming the case worldwide, and the European Respiratory Society (ERS) plays a significant role in this movement as attested to by a number of publications of all types in the European Respiratory Journal [1, 8, 10–14] and the European Respiratory Monograph series [15], and the endorsement by the ERS of the Dyspnea 2016 meeting organised by the International Dyspnea Society (www.dyspnea2016inparis.fr/sponsors/endorsement). Mindfulness-based cognitive therapy can improve well-being in COPD patients beyond usual therapeutic measures: this is additional evidence for a holistic approach to chronic breathlessness http://ow.ly/Dz2630irqvR

respiratory system
The therapeutic effect of tiotropium bromide on chronic obstructive pulmonary disease

Zhen-yi REN,Chun-xue BAI

DOI: https://doi.org/10.3760/cma.j.issn.1673-436X.2006.05.016

2006-01-01

Abstract:噻托溴胺(tiotropium bromide)是一个新型的用于治疗慢性阻塞性肺疾病(COPD)的吸入型支气管扩张药物,通过与M3受体结合,拮抗乙酰胆碱的作用,缓解支气管平滑肌的痉挛.吸入一次疗效持续24小时以上.几个大样本的临床试验结果表明,该药物对中重度COPD具有良好的疗效,在改善呼吸困难、生活质量、减少住院次数方面要优于沙美特罗,每日吸入一次噻托溴胺对支气管的舒张作用要明显好于每日吸入四次的溴化异丙托品和每日吸入两次的沙美特罗.而且该药物能够改善通气功能和肺容积,用药的耐受性和安全性也比较好。
Cognition on the diagnosis and treatment of COPD patients in different genders

Guoxia Wu,Wenjun Mi,Yahong Chen

DOI: https://doi.org/10.3760/cma.j.issn.1673-436X.2017.07.005

2017-01-01

Abstract:Objective To study the influence of different genders on COPD patient's cognition and behavior.Methods Collected the information of the patients in the stable phase who visited the department of respiratory medicine of peking university third hospital.With the cross-sectional study method,the researchers would ask the selected patients to complete face-to-face questionnaires about their recognition degree towards the COPD.The data was statistically analyzed through the SPSS 22.0 software.Results This study totally has selected 177 patients,among which,there were 126 males (71.2％) and 51 females (28.8％).There was no statistical difference in age,BMI and income for different genders of patients (P ＞0.05).Compared with male patients,the percentage of female patients who have never smoked was much higher (62.7％ vs 12.7％,P ＜0.01);the percentage of female ex smokers was lower (27.5％ vs 65.9％,P ＜0.01) while the pack-year of female smokers was obviously smaller than male patients [0(0-7.5) vs 30(10-45),P ＜0.01];both the percentage of female patients under primary school education level (21.6％ vs 6.3％,P ＜0.01) and the rate of unemployed female patients (29.4 ％ vs 11.9 ％,P ＜0.01) were much higher than male's.As to the lung functions,the FEV1 / FVC of female COPD patients was a little better than that of male ones [(58.7±9.8) ％ vs (55.0± 10.9) ％,P ＜0.05],while VC[(69.6-4-19.6) ％ vs (78.8 ± 19.5) ％,P ＜0.01] was lower than male's.Besides,the rate of female COPD patients who have complicated with cerebrovascular diseases was lower than that of male patients (0 vs 10.3％,P ＜0.05),while the percentage of female patients who knew the lung function results (17.6％ vs 7.9％,P =0.059) was higher than male's.Conclusions The female patients'cognition on the COPD and their behaviors in the treatment are different from those of male patients.Clinicians should pay close attention to female patients.
Pathophysiology foundation and clinic management of dyspnea

Haichao Li

DOI: https://doi.org/10.3760/cma.j.issn.1671-7368.2017.11.002

2017-01-01

BMJ

Abstract:呼吸困难是一组病因和发病机制不尽相同的呼吸不适的主观感受，呼吸困难受生理、心理、社会和环境因素的影响，其发生机制尚不完全清楚。呼吸困难特征的3种常见类型分别是呼吸用力/费力、空气饥饿感和胸闷，同一患者可有多种机制参与。呼吸困难的病因主要包括呼吸系统源性、心血管系统源性以及心因性疾病。与呼吸系统源性呼吸困难发生相关的主要环节包括呼吸中枢、呼吸泵和气血交换。心血管源性呼吸困难的主要原因包括心力衰竭、贫血和去适应。对呼吸困难病理生理机制的理解有助于呼吸困难的临床诊断和鉴别诊断以及对呼吸困难的正确处理。
A long-acting bronchodilator——tiotropium bromide

CHEN Wei,SHI Guochao

DOI: https://doi.org/10.3969/j.issn.1006-1533.2013.15.003

2013-01-01

Abstract:Chronic obstructive pulmonary disease and asthma are a chronic respiratory disease characterized by airflow obstruction, for which bronchodilator is one of the primary therapies. Tiotropium bromide is a long-acting anticholinergic bronchodilator. This review describes its pharmacological characteristics, clinical researches, tolerability and combined treatment with other drugs.
The clinical thinking about general treatment of lung cancer

蔡映云,范理宏

DOI: https://doi.org/10.3969/j.issn.1001-9057.2002.05.001

2002-01-01

Abstract:The clinical thinking about general treatment of lung cancer includes three parts:(1)how to make a treatment protocal;(2)how to perform the protocal;(3)how to evaluate it.There are several factors which influece the treatment protocal of lung cancer,such as the biological characters of the tumors,the local and general condition of the paitents and the indications and contraindications of each therapy.When performing the protocal,those relations must be reasonably dealt,it local treatment and general threatment,benefits and side effects,anti tumoral treatment and adjuvant treatment.We can evaluate the effects of the protocal according to the size of the mass of CT or X ray film,the surviving duration and the quality of life.

Clinical thinking of treatment with bronchodilator

Clinical Thinking on Diagnosis and Treatment of Pediatric Respiratory Infections

The clinical thinking about treatment of obstructive sleep apnea hyponea syndrome

Continuing Medical Education Clinical thinking of treatment of pneumothorax

Clinical Thinking on Diagnosis and Treatment of Childhood Bronchiolitis

Clinical thinking of mechanical ventilatim

A retrospective study of the treatment of patients hospitalized for asthma exacerbation in China

The patient who affects an asthma uses bronchus relaxation agent factor and countermeasure

Analysis of the Correct Use of Inhaled Medicines in Patient with Chronic Airway Diseases

Clinical Differential Diagnosis in Bronchial Asthma Patients with Chest Tightness Suggestive of Coronary Heart Disease by Peak Flow Meter

Clinical thought of signs and symptoms

Clinical Thinking of Drug Therapy Decisions

Clinical thinking of artificial airway

[Attitudes and Actions of Chronic Obstructive Pulmonary Disease Patients on Treatment:A National Multi-Center Investigative Study].

Assessment of Inhalation Technique in Clinical and Functional Control of Asthma and Chronic Obstructive Pulmonary Disease

Treat the lungs, fool the brain and appease the mind: towards holistic care of patients who suffer from chronic respiratory diseases

The therapeutic effect of tiotropium bromide on chronic obstructive pulmonary disease

Cognition on the diagnosis and treatment of COPD patients in different genders

Pathophysiology foundation and clinic management of dyspnea

A long-acting bronchodilator——tiotropium bromide

The clinical thinking about general treatment of lung cancer